螺内酯对慢性心力衰竭患者血浆脑钠肽水平及心功能的影响  被引量:3

Effects of spironolactone on cardiac function and plasma level of brain natriuretic peptide in patients with chronic heart failure

在线阅读下载全文

作  者:刘树琴[1] 庞英[1] 周敏[1] 张雪松[1] 

机构地区:[1]山东省聊城市人民医院心内科,山东聊城252000

出  处:《心血管康复医学杂志》2010年第6期640-642,共3页Chinese Journal of Cardiovascular Rehabilitation Medicine

摘  要:目的:探讨螺内酯对慢性心力衰竭(CHF)患者血浆脑钠肽(BNP)水平和心功能的影响。方法:64例CHF患者被随机分为常规对照组(32例)和螺内酯组(32例),两组均给予常规治疗,螺内酯组另加螺内酯20mg,2次/d,观察期3个月,测定治疗前、后左心室舒张末内径(LVEDd)、左心室射血分数(LVEF)、血浆BNP浓度的变化。结果:治疗3个月后,螺内酯组总有效率(90.6%)明显高于常规治疗组(81.3%,P<0.05);两组治疗后BNP、LVEDd较治疗前有显著下降,LVEF较治疗前显著升高(P均<0.01),螺内酯组血浆BNP浓度由(839±67)ng/L降至(359±51)ng/L(P<0.01),LVEDd由(66.01±3.7)mm降至(59.1±2.4)mm(P<0.05),LVEF由(36±1.2)%升至(49±5.9)%(P<0.01),且明显优于常规对照组(P<0.05)。结论:在常规心衰治疗的基础上加用螺内酯能明显改善心功能,显著降低血浆脑钠肽水平。Objective:To investigate the changes of cardiac function and plasma brain natriuretic peptide(BNP) level in patients with chronic heart failure(CHF) after spironolactone treatment.Methods:A total of 64 CHF patients were randomly divided into two groups,spironolactone group(n=32) and normal control group(n=32).Patients in spironolactone group were given spironolactone 20mg,2 times/d for three months beside conventional therapy.Plasma BNP level,left ventricular end-diastolic dimension(LVEDd) and left ventricular ejection fraction(LVEF) were evaluated before and after treatment.Results:After 3-month treatment,the overall effective rate of spironolactone group was significantly higher than that of normal control group(90.6% vs.81.3%,P〈0.05).Plasma BNP level,LVEDd and LVEF of the two groups were significantly improved compared with those of before treatment(P〈0.01all).In spironolactone group,plasma BNP concentration decreased from(839±67)ng/L to(359±51)ng/L(P〈0.01),LVEF increased from(36±1.2)% to(49±5.9)%(P〈0.01) and LVEDd decreased from(66.01±3.7)mm to(59.1±2.4)mm(P〈0.05),all these were significantly better than those of normal control group(P〈0.05).Conclusion:Based on conventional therapy,spironolactone can significantly improve cardiac function and decrease plasma brain natriuretic peptide in patients with chronic heart failure.

关 键 词:心力衰竭 充血性 利钠肽  螺内酯 

分 类 号:R541.61[医药卫生—心血管疾病]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象